acute urticaria
inflammatory skin disease institute
skin disorder infomation
chronic skin rash organization
hives relief skin disease information
Dedicated to improving the lives of the people with inflammatory skin disorders.
inflammatory skin disease awareness ABOUT ISDI
 
chronic skin rash information INFLAMMATORY SKIN DISEASES
 
patient advocacy PATIENT INFORMATION
 
dermatitis physician information MEDICAL PROVIDER INFORMATION
 
non-profit support SUPPORT ISDI
 
eczema research CURRENT NEWS/EVENTS
 
psoriasis education ISDI NEWSLETTER
 
rosacea awareness RESOURCE LINKS
 
dermatology award winner
  dermatitis research
psoriasis information

Buy Tacrolimus (Protopic, Prograf) online

How and where to order Protopic (Tacrolimus) ointment topical 0.03% and 0.1% in tubes 10 g and Prograf (Tacrolimus) 0.5 mg, 1 mg, 2 mg capsules or tablets online on the Inflammatory Skin Disease Institute (ISDI) website:

Protopic:MEDS FOR SALE - 5% discount coupon 5OFF
Prograf:DFH PHARMACY - 10% discount coupon DFH10
Shops:TACROLIMUS STORES
Prices:
  • from $25.74 per tube
  • from $3.09 per pill
  • Forms:
  • topical ointment 0.03% and 0.1% 10 g tubes
  • 0.5 mg, 1 mg, 2 mg capsules and tablets
  • Quantity:
  • 1-5 tubes
  • 10-80 pills
  • Type:
  • Tacrolimus brand
  • Protopic generic
  • Prograf generic
  • Payment:Visa, Mastercard, AmEx, Bitcoin
    Delivery:Regular and express mail service
    Shipping:Worldwide, including USA, UK, Europe, Canada, Australia


    Indications and usage for Protopic:

    Protopic (Tacrolimus) ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable.


    Contraindications:

    Protopic ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.


    Dosage and administration:

    Adult

    Protopic (Tacrolimus) ointment 0.03% and 0.1%:

  • Apply a thin layer of Protopic ointment to the affected skin twice daily. The minimum amount should be rubbed in gently and completely to control signs and symptoms of atopic dermatitis. Stop using when signs and symptoms of atopic dermatitis resolve.
  • If signs and symptoms (e.g. itch, rash, and redness) do not improve within 6 weeks, patients should be re-examined by their healthcare provider to confirm the diagnosis of atopic dermatitis.
  • Continuous long-term use of topical calcineurin inhibitors, including Protopic ointment should be avoided, and application should be limited to areas of involvement with atopic dermatitis.

    The safety of Tacrolimus (Protopic) under occlusion, which may promote systemic exposure, has not been evaluated. This medication should not be used with occlusive dressings.

    Pediatric: for children 2-15 years

    Protopic (Tacrolimus) ointment 0.03%:

  • Apply a thin layer of Protopic ointment, 0.03% to the affected skin twice daily. The minimum amount should be rubbed in gently and completely to control signs and symptoms of atopic dermatitis. Stop using when signs and symptoms of atopic dermatitis resolve.
  • If signs and symptoms (e.g. itch, rash, and redness) do not improve within 6 weeks, patients should be re-examined by their healthcare provider to confirm the diagnosis of atopic dermatitis.
  • Continuous long-term use of topical calcineurin inhibitors, including Protopic should be avoided, and application should be limited to areas of involvement with atopic dermatitis.

    The safety of this drug under occlusion, which may promote systemic exposure, has not been evaluated. Tacrolimus ointment should not be used with occlusive dressings.


    Dosage forms and strengths:

    Protopic (Tacrolimus) ointment for topical use 0.03% and 0.1% in tubes 10 g, 30 g, 60 g, 100 g.


    Overdosage:

    Tacrolimus (Protopic) ointment is not for oral use. Oral ingestion of this medicine may lead to adverse effects associated with systemic administration of tacrolimus. If oral ingestion occurs, medical advice should be sought.


    Warnings and precautions:

    Long-term safety of topical calcineurin inhibitors has not been established.

    Although a causal relationship has not been established, rare cases of malignancy (e.g., skin and lymphoma) have been reported in patients treated with topical calcineurin inhibitors, including Protopic (Tacrolimus) topica ointment.

    Continuous long-term use of topical calcineurin inhibitors, including Protopic, in any age group should be avoided, and application limited to areas of involvement with atopic dermatitis.

    Tacrolimus ointment is not indicated for use in children less than 2 years of age. Only 0.03% Protopic ointment is indicated for use in children 2-15 years of age.

    Related medications:

  • Cyclosporine (Neoral)
  • Prednisone tablets


    Adverse reactions, side effects:

    The most common adverse reactions of tacrolimus topical ointment are skin burning, pruritus, flu-like symptoms, allergic reaction, skin erythema, headache, skin infectiona, fever, accidental injury, otitis media, nausea, dry skin.

    To report suspected adverse reactions of Protopic (Tacrolimus) ointment, contact LEO pharmaceutical company or your local FDA.


    Use in specific populations:

    Pregnancy

    There are no adequate and well-controlled studies of topically administered tacrolimus in pregnant women. The experience with Protopic ointment when used by pregnant women is too limited to permit assessment of the safety of its use during pregnancy.

    Nursing mothers

    Although systemic absorption of tacrolimus following topical applications of Protopic topical ointment is minimal relative to systemic administration, it is known that tacrolimus is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from tacrolimus, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

    Pediatric use

    Only Protopic (Tacrolimus) ointment 0.03% is recommended for use as a second-line therapy for short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised children 2 to 15 years of age who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable.

    Geriatric use

    Four hundred and four (404) patients >= 65 years old received Tacrolimus (Protopic) ointment in phase 3 studies. The adverse event profile for these patients was consistent with that for other adult patients.


    Where to buy tacrolimus online:

    To purchase Protopic (Tacrolimus) ointment and Prograf (Tacrolimus) pills from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.


    Here is a list of popular medications containing tacrolimus as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
    Astagraf XL
  • Capsules, Extended Release; Oral; Tacrolimus 0.5 mg
  • Capsules, Extended Release; Oral; Tacrolimus 1 mg
  • Capsules, Extended Release; Oral; Tacrolimus 5 mg
  • Astellas Pharma
  • Prograf
  • Capsules; Oral; Tacrolimus 0.25 mg
  • Capsules; Oral; Tacrolimus 0.5 mg
  • Capsules; Oral; Tacrolimus 1 mg
  • Capsules; Oral; Tacrolimus 2 mg
  • Capsules; Oral; Tacrolimus 5 mg
  • Astellas Pharma
  • Adcock Ingram
  • DKSH
  • Firma Chun Cheong
  • Fujisawa
  • Gador
  • Janssen
  • Pharma Investi de Chile
  • Pro-Pharma
  • Teva
  • Vianex
  • Zuellig Pharma
  • Protopic
  • Ointment; Topical; Tacrolimus 0.03%
  • Ointment; Topical; Tacrolimus 0.1%
  • LEO Pharma
  • Astellas Pharma
  • DKSH
  • Firma Chun Cheong
  • Fujisawa
  • Gador
  • Janssen
  • Roche
  • Teva
  • Vianex
  • Zuellig Pharma


  • skin atopic dermatitis education
    severe acene remedy information
    inflammatory skin disease organization skin disorder advocate
    [ABOUT US] [SKIN DISEASES] [PATIENT INFO ] [MEDICAL INFO] [TACROLIMUS ] [DONATE] [NEWS/EVENTS ] [NEWSLETTER] [LINKS ] [HOME] [SITE MAP]
    eczema support
    acne problems
    perioral dermatitis rosacea support
    Copyright © 2001 - 2022 Inflammatory Skin Disease Institute (ISDI), Inc. All Rights Reserved.
    psoriasis research